PAPER
Kinetic Resolution of Secondary Alcohols by Oxidative Esterification
1979
r.t. for 2 h and silica gel chromatography (pentane–Et2O, 50:1 to
mer tR = 7.1 min. The absolute configuration of the major enantio-
20:1) to afford 15d as a light yellow solid; yield: 85 mg (51%).
mer was not assigned.
FTIR (neat): 3422, 2954, 2937, 2392, 2294, 1716, 1597, 1577,
1442, 1275, 1113, 1099, 1070, 800, 778, 730 cm–1.
1H NMR (300 MHz, CDCl3): d = 8.30–8.05 (m, 5 H), 7.95–7.78 (m,
2 H), 7.70 (d, J = 6.9 Hz, 1 H), 7.61–7.42 (m, 3 H), 6.90 (q, J = 6.6
Hz, 1 H), 3.95 (s, 3 H), 1.86 (d, J = 6.6 Hz, 3 H).
13C NMR (75 MHz, CDCl3): d = 166.4, 165.2, 137.3, 134.4, 134.1,
134.0, 130.4, 129.8, 129.7, 129.1, 128.8, 126.6, 125.9, 125.5, 123.5,
123.3, 71.0, 52.5, 22.0.
1-(1-Naphthyl)ethyl 2-Methylbenzoate (15g)
According to GP I with 2-methylbenzaldehyde (2g; 30 mg, 0.25
mmol), DBU (42 mg, 0.28 mmol), catalyst 8 (6.8 mg, 12.5 mmol),
1-(1-naphthyl)ethanol (4a; 129 mg, 750 mmol) and 3,3¢,5,5¢-tetra-
tert-butyldiphenoquinone (14; 102 mg, 250 mmol) in THF (2.5 mL)
at r.t. for 12 h and silica gel chromatography (pentane–Et2O, 100:1
to 50:1) to afford 15g as a yellow oil; yield: 43 mg (59%).
FTIR (neat): 2977, 1702, 1598, 1448, 1248, 1071, 862, 740 cm–1.
HRMS (ESI): m/z [M + Na]+ calcd for C21H18O4Na: 357.1097;
found: 357.1090.
1H NMR (300 MHz, CDCl3): d = 8.18 (d, J = 8.4 Hz, 1 H), 7.99 (d,
J = 7.6 Hz, 1 H), 7.87 (d, J = 7.9 Hz, 1 H), 7.80 (d, J = 8.2 Hz, 1 H),
7.69 (d, J = 7.1 Hz, 1 H), 7.59–7.43 (m, 3 H), 7.38 (t, J = 7.4 Hz, 1
H), 7.24 (t, J = 7.2 Hz, 2 H), 6.89 (q, J = 6.6 Hz, 1 H), 2.59 (s, 3 H),
1.83 (d, J = 6.6 Hz, 3 H).
13C NMR (75 MHz, CDCl3): d = 166.8, 140.3, 137.6, 133.9, 131.9,
131.7, 130.6, 130.3, 129.9, 128.9, 128.4, 126.3, 125.7, 125.7, 125.4,
123.2, 123.2, 69.9, 21.9, 21.7.
The enantiomeric excess (38%) was determined by chiral HPLC;
column: Chiralpak AD-H; solvent: cyclohexane–i-PrOH (99.5:0.5);
flow: 1.0 mL/min; major enantiomer tR = 17.9 min, minor enantio-
mer tR = 19.6 min. The absolute configuration of the major enantio-
mer was not assigned.
1-(1-Naphthyl)ethyl 4-Nitrobenzoate (15e)
HRMS (ESI): m/z [M + Na]+ calcd for C20H18O2Na: 313.1199;
found: 313.1202.
According to GP I with 4-nitrobenzaldehyde (2e; 76 mg, 0.5 mmol),
DBU (83 mg, 0.55 mmol), catalyst 8 (13.5 mg, 25 mmol), 1-(1-
naphthyl)ethanol (4a; 258 mg, 1.5 mmol) and 3,3¢,5,5¢-tetra-tert-
butyldiphenoquinone (14; 205 mg, 500 mmol) in THF (5.0 mL) at
r.t. for 2 h and silica gel chromatography (pentane–Et2O, 50:1 to
20:1) to afford 15e as a yellow oil; yield: 108 mg (67%).
The enantiomeric excess (37%) was determined by chiral HPLC;
column: Chiralpak AD-H; solvent: cyclohexane–i-PrOH (99.5:0.5);
flow: 1.0 mL/min; major enantiomer tR = 7.0 min, minor enantio-
mer tR = 5.4 min. The absolute configuration of the major enantio-
mer was not assigned.
FTIR (neat): 3054, 2985, 2389, 2349, 2280, 1720, 1604, 1525,
1268, 1101, 777, 718 cm–1.
1H NMR (300 MHz, CDCl3): d = 8.31–8.22 (m, 4 H), 8.18 (d,
J = 8.4 Hz, 1 H), 7.94–7.81 (m, 2 H), 7.70 (d, J = 6.9 Hz, 1 H),
7.62–7.47 (m, 3 H), 6.93 (q, J = 6.6 Hz, 1 H), 1.90 (d, J = 6.6 Hz, 3
H).
13C NMR (75 MHz, CDCl3): d = 164.1, 150.7, 136.9, 136.0, 134.0,
131.0, 129.2, 129.0, 126.7, 126.0, 125.5, 123.7, 123.5, 123.1, 71.6,
21.9.
1-(1-Naphthyl)ethyl 3-Chlorobenzoate (15h)
According to GP I with 3-chlorobenzaldehyde (2h; 35 mg, 0.25
mmol), DBU (42 mg, 0.28 mmol), catalyst 8 (6.8 mg, 12.5 mmol),
1-(1-naphthyl)ethanol (4a; 129 mg, 750 mmol) and 3,3¢,5,5¢-tetra-
tert-butyldiphenoquinone (14; 102 mg, 250 mmol) in THF (2.5 mL)
at r.t. for 12 h and silica gel chromatography (pentane–Et2O, 100:1
to 50:1) to afford 15h as a yellow oil; yield: 52 mg (67%).
FTIR (neat): 3064, 1719, 1576, 1426, 1254, 1125, 1072, 902, 743,
630 cm–1.
HRMS (ESI): m/z [M + Na]+ calcd for C19H15NO4Na: 344.0893;
1H NMR (300 MHz, CDCl3): d = 8.18 (d, J = 8.3 Hz, 1 H), 8.09 (s,
1 H), 8.00 (d, J = 7.8 Hz, 1 H), 7.90 (d, J = 7.9 Hz, 1 H), 7.84 (d,
J = 8.2 Hz, 1 H), 7.70 (d, J = 7.1 Hz, 1 H), 7.62–7.46 (m, 4 H), 7.38
(t, J = 7.9 Hz, 1 H), 6.91 (q, J = 6.6 Hz, 1 H), 1.86 (d, J = 6.6 Hz, 3
H).
13C NMR (75 MHz, CDCl3): d = 164.6, 137.2, 134.5, 133.9, 133.0,
132.2, 130.3, 129.7, 129.7, 129.0, 128.6, 127.8, 126.4, 125.7, 125.4,
123.3, 123.1, 70.7, 21.8.
found: 344.0889.
The enantiomeric excess (14%) was determined by chiral HPLC;
column: Chiralpak AD-H; solvent: cyclohexane–i-PrOH (99.5:0.5);
flow: 1.0 mL/min; major enantiomer tR = 16.4 min, minor enantio-
mer tR = 14.5 min. The absolute configuration of the major enantio-
mer was not assigned.
1-(1-Naphthyl)ethyl 2-Bromobenzoate (15f)
According to GP I with 2-bromobenzaldehyde (2f; 46.3 mg, 0.25
mmol), DBU (42 mg, 0.28 mmol), catalyst 8 (6.8 mg, 12.5 mmol),
1-(1-naphthyl)ethanol (4a; 129 mg, 750 mmol) and 3,3¢,5,5¢-tetra-
tert-butyldiphenoquinone (14; 102 mg, 250 mmol) in THF (2.5 mL)
at r.t. for 12 h and silica gel chromatography (pentane–Et2O, 100:1
to 50:1) to afford 15f as a viscous yellow oil; yield: 58 mg (65%).
HRMS (ESI): m/z [M + Na]+ calcd for C19H15ClO2Na: 333.0653;
found: 333.0654.
The enantiomeric excess (42%) was determined by chiral HPLC;
column: Chiralpak AD-H; solvent: cyclohexane–i-PrOH (99.5:0.5);
flow: 1.0 mL/min; major enantiomer tR = 8.3 min, minor enantio-
mer tR = 7.1 min. The absolute configuration of the major enantio-
mer was not assigned.
FTIR (neat): 3057, 1725, 1591, 1437, 1250, 1112, 1034, 746 cm–1.
1H NMR (300 MHz, CDCl3): d = 8.12 (d, J = 8.4 Hz, 1 H), 7.82 (d,
J = 8.3 Hz, 1 H), 7.79–7.71 (m, 2 H), 7.66 (d, J = 7.1 Hz, 1 H),
7.63–7.57 (m, 1 H), 7.55–7.37 (m, 3 H), 7.32–7.17 (m, 2 H), 6.87
(q, J = 6.6 Hz, 1 H), 1.81 (d, J = 6.6 Hz, 3 H).
13C NMR (75 MHz, CDCl3): d = 165.5, 137.0, 134.3, 133.8, 132.5,
132.4, 131.3, 130.3, 128.9, 128.6, 127.1, 126.4, 125.7, 125.4, 123.5,
123.2, 121.7, 71.1, 21.7.
1-(1-Naphthyl)ethyl 2-Naphthoate (15i)
According to GP I with 2-naphthaldehyde (2i; 39 mg, 0.25 mmol),
DBU (42 mg, 0.28 mmol), catalyst 8 (6.8 mg, 12.5 mmol), 1-(1-
naphthyl)ethanol (4a; 129 mg, 750 mmol) and 3,3¢,5,5¢-tetra-tert-
butyldiphenoquinone (14; 102 mg, 250 mmol) in THF (2.5 mL) at
r.t. for 12 h and silica gel chromatography (pentane–Et2O, 50:1 to
20:1) to afford 15i as a light yellow solid; yield: 55 mg (68%).
HRMS (ESI): m/z [M + Na]+ calcd for C19H15BrO2Na: 377.0148;
found: 377.0153.
FTIR (neat): 3050, 1712, 1628, 1507, 1445, 1355, 1271, 1222,
1086, 977, 766 cm–1.
1H NMR (300 MHz, CDCl3): d = 8.69 (s, 1 H), 8.25 (d, J = 8.4 Hz,
1 H), 8.14 (dd, J = 8.6, 1.5 Hz, 1 H), 7.97 (d, J = 7.7 Hz, 1 H), 7.93–
The enantiomeric excess (60%) was determined by chiral HPLC;
column: Chiralpak AD-H; solvent: cyclohexane–i-PrOH (99.5:0.5);
flow: 1.0 mL/min; major enantiomer tR = 10.3 min, minor enantio-
Synthesis 2011, No. 12, 1974–1983 © Thieme Stuttgart · New York